Fonar Corp (FONR)
16.34
+0.33
(+2.06%)
USD |
NASDAQ |
May 02, 16:00
16.26
-0.08
(-0.49%)
After-Hours: 20:00
Fonar Market Cap: 105.49M for May 2, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 02, 2024 | 105.49M |
| May 01, 2024 | 103.36M |
| April 30, 2024 | 101.62M |
| April 29, 2024 | 103.88M |
| April 26, 2024 | 105.04M |
| April 25, 2024 | 108.85M |
| April 24, 2024 | 104.52M |
| April 23, 2024 | 103.36M |
| April 22, 2024 | 104.59M |
| April 19, 2024 | 108.52M |
| April 18, 2024 | 108.62M |
| April 17, 2024 | 106.65M |
| April 16, 2024 | 108.39M |
| April 15, 2024 | 108.65M |
| April 12, 2024 | 110.78M |
| April 11, 2024 | 113.88M |
| April 10, 2024 | 116.59M |
| April 09, 2024 | 123.31M |
| April 08, 2024 | 121.05M |
| April 05, 2024 | 126.15M |
| April 04, 2024 | 127.99M |
| April 03, 2024 | 127.25M |
| April 02, 2024 | 129.44M |
| April 01, 2024 | 131.83M |
| March 28, 2024 | 137.90M |
| Date | Value |
|---|---|
| March 27, 2024 | 140.67M |
| March 26, 2024 | 140.16M |
| March 25, 2024 | 141.06M |
| March 22, 2024 | 143.84M |
| March 21, 2024 | 144.22M |
| March 20, 2024 | 143.51M |
| March 19, 2024 | 136.48M |
| March 18, 2024 | 139.51M |
| March 15, 2024 | 141.32M |
| March 14, 2024 | 143.64M |
| March 13, 2024 | 146.68M |
| March 12, 2024 | 148.49M |
| March 11, 2024 | 143.39M |
| March 08, 2024 | 146.23M |
| March 07, 2024 | 149.52M |
| March 06, 2024 | 146.48M |
| March 05, 2024 | 149.32M |
| March 04, 2024 | 148.42M |
| March 01, 2024 | 145.26M |
| February 29, 2024 | 143.77M |
| February 28, 2024 | 148.49M |
| February 27, 2024 | 148.74M |
| February 26, 2024 | 150.04M |
| February 23, 2024 | 147.32M |
| February 22, 2024 | 144.55M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
73.71M
Minimum
Mar 16 2020
174.17M
Maximum
Aug 11 2020
121.56M
Average
119.80M
Median
Mar 06 2020
Market Cap Benchmarks
| XWELL Inc | 7.405M |
| ProPhase Labs Inc | 101.31M |
| Applied DNA Sciences Inc | 3.517M |
| Veracyte Inc | 1.516B |
| OncoCyte Corp | 37.07M |
Market Cap Related Metrics
| PE Ratio | 8.880 |
| PS Ratio | 1.058 |
| PEG Ratio | 0.1881 |
| Price to Book Value | 0.6437 |
| Price to Free Cash Flow | 8.898 |
| Price | 16.34 |
| Earnings Yield | 11.26% |
| PEGY Ratio | 0.1881 |
| Operating PE Ratio | 5.987 |
| Normalized PE Ratio | 10.12 |